US 12077785
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 12077785 (Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof) held by SOTIO BIOTECH INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SOTIO BIOTECH INC.
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/53, A61K2239/55